Mark Sheptoff Financial Planning’s Century Therapeutics IPSC Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23K	Hold	500	–	–	﹤0.01%	493
2026 Q1	$1.15K	Hold	500	–	–	﹤0.01%	483
2025 Q4	$497	Hold	500	–	–	﹤0.01%	492
2025 Q3	$249	Hold	500	–	–	﹤0.01%	472
2025 Q2	$279	Hold	500	–	–	﹤0.01%	503
2025 Q1	$238	Hold	500	–	–	﹤0.01%	436
2024 Q4	$505	Hold	500	–	–	﹤0.01%	416
2024 Q3	$855	Buy	+500	New	+$980	﹤0.01%	407

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Mark Sheptoff Financial Planning's IPSC Position: Q2 2026 in Review

Mark Sheptoff Financial Planning held its Century Therapeutics (IPSC) position steady in Q2 2026 at 500 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Mark Sheptoff Financial Planning first reported a position in IPSC in Q3 2024 and has held it in 8 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Mark Sheptoff Financial Planning held 500 shares of Century Therapeutics worth $1.23K as of Q2 2026.
Mark Sheptoff Financial Planning left its Century Therapeutics share count unchanged in Q2 2026.
Century Therapeutics made up ﹤0.01% of Mark Sheptoff Financial Planning's portfolio in Q2 2026, its #493 holding.
Mark Sheptoff Financial Planning first reported a position in Century Therapeutics in Q3 2024 and has held it in 8 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q2 2026, filed 13 Aug 2026.